Published Online:
July 16, 2008
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of various calcium channel blockers for primary Raynaud's phenomenon as determined by attack rates, severity scores, patient preference scores and physiological measurements.
